US Reclassifies Medical Marijuana

Acting Attorney General Todd Blanche executed the directive on Thursday, moving certain marijuana products out of the most restrictive Schedule I category.

While the action does not legalize marijuana at the federal level, it aligns medical cannabis with substances like ketamine and anabolic steroids.

Industry experts anticipate the change will spark a surge in investment and allow for more robust clinical studies.

However, some Republican lawmakers have criticized the decision, citing concerns over public safety and increased potency.